<DOC>
	<DOCNO>NCT00346190</DOCNO>
	<brief_summary>To determine whether administration Alendronate early effective late prevention osteoporosis follow hip fracture</brief_summary>
	<brief_title>The Study Early Administration Alendronate Prevention Bone Loss After Hip Fracture .</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Male Female age &gt; 55 Low trauma hip fracture 90 day Be willing submit periodic bone mineral density radiographic study spine &amp; 24 hr urine collection Written inform consent Disorders know affect bone metabolism Not take bisphosphonates within last 6 month Drugs know interfere calcium metabolism within lat 6 month prior hip fracture serum calcium &gt; 2.65 mmol/L Treatment investigational drug within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>